Clinithink and Healthix – the largest public health information exchange (HIE) in the U.S. – are partnering on a program designed to leverage Healthix clinical data to facilitate assessment of pre-trial feasibility, ensuring the validity of protocol design. The new program aims to improve population health in New York City and Long Island by eventually making cutting-edge treatments available to patients.
Healthix Data & Clinithink AI – A Blueprint for Insight
With health data of over 17 million individuals, Healthix spans a comprehensive range of organizations, from large hospital systems and health plans to small community health centers and physician practices. Over one thousand organizations, across more than 7,000 facilities, are connected through Healthix, contributing a rich clinical data set that is updated with each patient encounter. Clinithink’s artificial intelligence and clinical natural language processing (AI/CNLP) platform will run queries on this HIE data to generate insights that can be used to improve patient wellbeing, both now and in the future.
Why It Matters
“We are constantly looking for ways to deliver enhanced value to our patients and the healthcare community. Our partnership with Clinithink uniquely positions us to support an important industry need by driving innovation and supporting efficiencies in the design and implementation of clinical trials – all while remaining compliant with New York’s privacy policy guidelines,” said Todd M. Rogow, President and CEO of Healthix.
While some health systems have already experienced moderate success in achieving these insights, the key difference for Healthix is that they connect multiple health systems in various settings, making them a valuable partner for Clinithink.
